|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes (source: EMA (2009)) |
IUPAC Name ![]() |
| N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 7392 | agomelatine |
Synonyms ![]() |
| S20098 |
| Thymanax® |
| Valdoxan® |
Database Links ![]() |
|
| BindingDB Ligand | 50035179 |
| CAS Registry No. | 138112-76-2 (source: Scifinder) |
| ChEMBL Ligand | CHEMBL10878 |
| DrugBank Ligand | DB06594 |
| PubChem CID | 82148 |
| Search Google for chemical match using the InChIKey | YJYPHIXNFHFHND-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | YJYPHIXNFHFHND |
| Search PubMed clinical trials | agomelatine |
| Search PubMed titles | agomelatine |
| Search PubMed titles/abstracts | agomelatine |
| Wikipedia | Agomelatine |
| Comments |
| Agomelatine is a melatonergic (i.e. it acts as a a melatonin receptor agonist) antidepressant, devoid of the side-effects caused by SSRI, SNRI and tricyclic antidepressants. The drug also has low affinity for 5-HT2C receptors. |